Skip to main content
Friday
February 13, 2026
Sign In
Subscribe
Latest
Economy
Banking
Stocks
Industry
Analysis
Bazaar
RMG
Corporates
Aviation
Videos
TBS Today
TBS Stories
TBS World
News of the day
TBS Programs
Podcast
Editor's Pick
World+Biz
Features
Panorama
The Big Picture
Pursuit
Habitat
Thoughts
Splash
Mode
Tech
Explorer
Brands
In Focus
Book Review
Earth
Food
Luxury
Wheels
Subscribe
Get the Paper
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Bangladesh
Supplement
Infograph
Explainer
Archive
Gallery
Long Read
Interviews
Offbeat
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
FEBRUARY 13, 2026
AstraZeneca vaccine
AstraZeneca vaccine
The world needs the not-for-profit Astrazeneca vaccine, minus the Astrazeneca drama
Questions about AstraZeneca jab linger
US puts J&J in charge of plant that botched Covid vaccine, removes AstraZeneca
Dutch temporarily halt AstraZeneca shots for under-60s
Astra vaccine haunts countries that shunned more expensive shots
Germany limits general use of AstraZeneca jabs to people under 60
Covax expects full vaccine supplies from India's Serum in May, says Unicef
Missteps could mar long-term credibility of AstraZeneca shot
AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID
Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe
AstraZeneca vaccine 79% effective in US trial
Poll points to AstraZeneca concerns as Europe protests grow
How worried should we be about reports of blood clots and AstraZeneca's vaccine?
Show More